A Phase 2b Diabetic Kidney Disease Study

Clinical trial NCT04170543 · COMPLETED

Trial details

NCT number: NCT04170543
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Kidney Disease

Start date: 2019-11-18
Primary completion: 2023-05-16
Enrollment: 609

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.